USANA Health Sciences, Inc. (NYSE:USNA) Major Shareholder Sells $607,724.88 in Stock

USANA Health Sciences, Inc. (NYSE:USNAGet Free Report) major shareholder Myron W. Wentz sold 13,496 shares of the firm’s stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $45.03, for a total value of $607,724.88. Following the transaction, the insider now directly owns 7,864,345 shares in the company, valued at $354,131,455.35. The sale was disclosed in a document filed with the SEC, which is available at this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

USANA Health Sciences Price Performance

Shares of USANA Health Sciences stock opened at $44.96 on Monday. The business’s 50 day simple moving average is $46.10 and its two-hundred day simple moving average is $48.23. The stock has a market capitalization of $856.49 million, a P/E ratio of 14.01, a price-to-earnings-growth ratio of 1.35 and a beta of 0.93. USANA Health Sciences, Inc. has a one year low of $41.45 and a one year high of $69.60.

USANA Health Sciences (NYSE:USNAGet Free Report) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.17. The business had revenue of $227.80 million for the quarter, compared to analysts’ expectations of $223.27 million. USANA Health Sciences had a return on equity of 12.80% and a net margin of 6.88%. Sell-side analysts expect that USANA Health Sciences, Inc. will post 2.78 earnings per share for the current fiscal year.

Hedge Funds Weigh In On USANA Health Sciences

A number of large investors have recently bought and sold shares of USNA. CWM LLC grew its position in shares of USANA Health Sciences by 21.8% in the 1st quarter. CWM LLC now owns 1,543 shares of the company’s stock worth $75,000 after buying an additional 276 shares during the last quarter. New York State Common Retirement Fund boosted its position in shares of USANA Health Sciences by 1.2% during the fourth quarter. New York State Common Retirement Fund now owns 24,500 shares of the company’s stock valued at $1,313,000 after purchasing an additional 279 shares in the last quarter. Swiss National Bank boosted its position in shares of USANA Health Sciences by 1.2% during the third quarter. Swiss National Bank now owns 25,500 shares of the company’s stock valued at $1,495,000 after purchasing an additional 300 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of USANA Health Sciences by 9.2% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock valued at $284,000 after purchasing an additional 494 shares in the last quarter. Finally, Rhumbline Advisers boosted its position in shares of USANA Health Sciences by 1.4% during the third quarter. Rhumbline Advisers now owns 34,942 shares of the company’s stock valued at $2,048,000 after purchasing an additional 496 shares in the last quarter. 54.25% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, DA Davidson decreased their price objective on USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating on the stock in a report on Tuesday, May 7th.

Check Out Our Latest Analysis on USANA Health Sciences

USANA Health Sciences Company Profile

(Get Free Report)

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.

Recommended Stories

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.